The European Commission (EC) has approved AstraZeneca’s Bydureon BCise ... better weight loss results and a new injection pen. AstraZeneca announced that the EC green-lighted the new formulation ...
Hosted on MSN1mon
Diabetes drug similar to Ozempic showed no benefits for patients with Parkinson’s diseaseHalf of the participants received a weekly injection of two milligrams ... for people with Parkinson’s disease. Exenatide, marketed as Byetta, is mainly used to help people with Type 2 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback